Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher disease

British Journal of Haematology

Volumn 133, Issue 1, 2006, Pages 93-97

  Magal, Itai ^a   Lebel, Ehud ^a   Altarescu, Gheona ^a   Itzchaki, Menachem ^a   Rudensky, Bernard ^a   Joseph Foldes, A ^b   Zimran, Ari ^a   Elstein, Deborah ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Bone mineral density; Enzyme replacement therapy; Gaucher disease; Osteoclasts; Osteoprotegerin; Osteoprotegerin polymorphisms

Indexed keywords

BIOLOGICAL MARKER; OSTEOPROTEGERIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE; BONE DENSITY; BONE DISEASE; CAUCASIAN; CELL ACTIVITY; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GAUCHER DISEASE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; JEW; MAJOR CLINICAL STUDY; MALE; OSTEOCLAST; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZATION; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BONE DENSITY; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GAUCHER DISEASE; GENOTYPE; GLYCOPROTEINS; HUMANS; JEWS; MALE; MIDDLE AGED; OSTEOPROTEGERIN; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 33644648290     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.05978.x     Document Type: Article

References (18)

1. Allen M.J. Myer B.J. Khokher A.M. Rushton N. Cox T.M. 1997 Pro-inflammatory cytokines and the pathogenesis of Gaucher disease: increased release of interleukin-6 and interleukin-10 The Quarterly Journal of Medicine 90 19 25
2. Barton N.W. Brady R.O. Dambrosia J.M. Di Bisceglie A.M. Doppelt S.H. Hill S.C. Mankin H.J. Murray G.J. Parker R.I. Argoff C.E. Grewal R.P. Yu K.-T. 1991 Replacement therapy for inherited enzyme deficiency: macrophage-targeted glucocerebrosidase for Gaucher's disease New England Journal of Medicine 324 1464 1470
3. Beutler E. Grabowski G.A. 2001 Gaucher disease In: The Metabolic and Molecular Bases of Inherited Diseases Vol III ed. by Scriver C.R. Valle D. Beudet A. Sly W.S. pp 3635 3668 McGraw-Hill New York, NY, USA
4. Brandstrom H. Stiger F. Lind L. Kahan T. Melhus H. Kindmark A. 2002 A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and function Biochemical and Biophysical Research Communications 293 13 17
5. Brandstrom H. Gerdhem P. Stiger F. Obrant K.J. Melhus H. Ljunggren O. Kindmark A. Akesson K. 2004 Single nucleotide polymorphisms in the human gene for osteoprotegerin are not related to bone mineral density or fracture in elderly women Calcified Tissue International 74 18 24
6. Elstein D. Hadas-Halpern I. Itzchaki M. Lahad A. Abrahamov A. Zimran A. 1996 Effect of low-dose enzyme replacement therapy on bones in Gaucher disease patients with severe skeletal involvement Blood Cells, Molecules, and Diseases 15 104 111
7. Elstein D. Itzchaki M. Mankin H.J. 1997 Skeletal involvement in Gaucher's disease Clinics in Haematology 10 793 816
8. Jorgensen H.L. Kusk P. Madsen B. Fenger M. Lauritzen J.B. 2004 Serum osteoprotegerin (OPG) and the A163G polymorphism in the OPG promoter region are related to peripheral measures of bone mass and fracture odds ratios Journal of Bone and Mineral Metabolism 22 132 138
9. Lacey D.L. Timms E. Tan H.L. Kelley M.J. Dunstan C.R. Burgess T. Elliott R. Colombero A. Elliott G. Scully S. Hsu H. Sullivan J. Hawkins N. Davy E. Capparelli C. Eli A. Qian Y.X. Kaufman S. Sarosi I. Shalhoub V. Senaldi G. Guo J. Delaney J. Boyle W.J. 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation Cell 93 165 176
10. Langdahl B.L. Carstens M. Stenkjaer L. Eriksen E.F. 2002 Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures Journal of Bone and Mineral Research 17 1245 1255
11. Lichtenstein M. Zimran A. Horowitz M. 1997 Cytokine mRNA in Gaucher disease Blood Cells, Molecules, and Diseases 23 395 401
12. Merkel K.D. Erdmann J.M. McHugh K.P. Abu-Amer Y. Ross F.P. Teitelbaum S.L. 1999 Tumor necrosis factor-alpha mediates orthopedic implant osteolysis American Journal of Pathology 154 203 210
13. Pacifici R. Rifas L. Teitelbaum S. Slatopolsky E. McCracken R. Bergfeld M. Lee W. Avioli L.V. Peck W.A. 1987 Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis Proceedings of the National Academy of Sciences of the United States of America 84 4616 4620
14. Raisz L.G. 1988 Local and systemic factors in the pathogenesis of osteoporosis New England Journal of Medicine 318 818 828
15. Roodman G.D. 2001 Biology of osteoclast activation in cancer Journal of Clinical Oncology 19 3562 3571
16. Rosenthal D.I. Doppelt S.H. Mankin H.J. Dambrosia J.M. Xavier R.J. McKusick K.A. Rosen B.R. Baker J. Niklason L.T. Hill S.C. Miller S.P.F. Brady R.O. Barton N.W. 1995 Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase Pediatrics 95 629 637
17. Simonet W.S. Lacey D.L. Dunstan C.R. Kelley M. Chang M.S. Luthy R. Nguyen H.Q. Wooden S. Bennett L. Boone T. Shimamoto G. DeRose M. Elliott R. Colombero A. Tan H.L. Trail G. Sullivan J. Davy E. Bucay N. Renshaw-Gegg L. Hughes T.M. Hill D. Pattison W. Campbell P. Sanders S. Van G. Tarpley J. Derby P. Lee R. Boyle W.J. 1997 Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 89 309 319
18. Zimran A. Sorge J. Gross E. Kubitz M. West C. Beutler E. 1989 Prediction of severity of Gaucher's disease by identification of mutations at DNA level Lancet 2 349 353